Targeted Disruption of TGF-β/Smad3 Signaling Modulates Skin Fibrosis in a Mouse Model of Scleroderma
Gabriella Lakos(Thermo Fisher Scientific (United Kingdom)), John Varga(Michigan Medicine)
Cited by 213
Related Papers
Systemic sclerosis: a prototypic multisystem fibrotic disorder
|Journal of Clinical Investigation|2007|1.1k
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
|American Journal Of Pathology|2009|227
Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?
|Arthritis & Rheumatism|2011|211